1416 FALDAPREVIR PLUS PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN IN CHRONIC HCV GENOTYPE-1 TREATMENT-NAÏVE PATIENTS: FINAL RESULTS FROM STARTVERSO1, A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III TRIAL

2013 ◽  
Vol 58 ◽  
pp. S569-S570 ◽  
Author(s):  
P. Ferenci ◽  
T. Asselah ◽  
G.R. Foster ◽  
S. Zeuzem ◽  
C. Sarrazin ◽  
...  
Keyword(s):  
Pegylated Interferon ◽  
Interferon Alfa ◽  
Phase Iii ◽  
Genotype 1 ◽  
Double Blind ◽  
Phase Iii Trial ◽  
Treatment Naïve ◽  
Pegylated Interferon Alfa ◽  
Hcv Genotype 1 ◽  
Chronic Hcv

1413 SIMEPREVIR (TMC435) WITH PEGINTERFERON/RIBAVIRIN FOR TREATMENT OF CHRONIC HCV GENOTYPE-1 INFECTION IN TREATMENT-NAÏVE PATIENTS: RESULTS FROM QUEST-2, A PHASE III TRIAL

2013 ◽  
Vol 58 ◽  
pp. S568 ◽  
Author(s):  
M. Manns ◽  
P. Marcellin ◽  
F.P. Fred Poordad ◽  
E. Stanislau Affonso de Araujo ◽  
M. Buti ◽  
...  
Keyword(s):  
Phase Iii ◽  
Genotype 1 ◽  
Phase Iii Trial ◽  
Hcv Genotype ◽  
Treatment Naïve ◽  
Hcv Genotype 1 ◽  
Chronic Hcv

869a Simeprevir (TMC435) With Peginterferon/Ribavirin for Treatment of Chronic HCV Genotype-1 Infection in Treatment-Naive Patients: Results From QUEST-2, a Phase III Trial

2013 ◽  
Vol 144 (5) ◽  
pp. S-151 ◽  
Author(s):  
Fred Poordad ◽  
Michael P. Manns ◽  
Patrick Marcellin ◽  
Evaldo Stanislau Affonso de Araujo ◽  
Maria Buti ◽  
...  
Keyword(s):  
Phase Iii ◽  
Genotype 1 ◽  
Phase Iii Trial ◽  
Hcv Genotype ◽  
Treatment Naïve ◽  
Hcv Genotype 1 ◽  
Chronic Hcv
Sign in / Sign up

Export Citation Format

Share Document